Abstract
Symptoms that are not completely explicable, such as mastalgia, might cause individuals to experience more apprehension regarding health and to visit doctors more frequently. No study has been found in the literature that assessed the level of somatosensory amplification of patients with mastalgia. This study is intended to assess the levels of somatosensory amplification of patients who complain of mastalgia and to compare them to a healthy control group. Forty patients with the diagnosis of non-cyclical mastalgia and 41 voluntary controls were incorporated in the study. All patients participating in the study were assessed using the Somatosensory Amplification Scale (SSAS), Health Anxiety Inventory (HAI), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI). The scores of SSAS, HAI, BAI, and BDI for the patient group were higher than those for the control group. Upon a simple regression analysis, the effect of education duration in mastalgia group on HAI was 12.4%, the effect of anxiety level on SSAS was 28%, and that of the depression level on HAI was 10.8%. Patients with mastalgia exhibited higher levels of somatosensory amplification, depression, anxiety, and health anxiety than the control group. The idiopathic symptoms might cause individuals to develop a higher level of somatosensory amplification and to perceive bodily symptoms more severely. Furthermore, such symptoms might further produce anxiety and depressive symptoms due to the higher perception by the individuals with apprehension related to their health.
Similar content being viewed by others
References
Kataria K, Dhar A, Srivastava A, Kumar S, Goyal A (2014) A systematic review of current understanding and management of mastalgia. Indian J Surg 76:217–222. https://doi.org/10.1007/s12262-013-0813-8
Hafiz SP, Barnes NLP, Kirwan CC (2018) Clinical management of idiopathic mastalgia: a systematic review. J Prim Health Care 10:312–323. https://doi.org/10.1071/HC18026
Preece PE, Mansel RE, Hughes LE (1978) Mastalgia: psychoneurosis or organic disease? BMJ 1:29–30. https://doi.org/10.1136/bmj.1.6104.29
Jenkins PL, Jamil N, Gateley C, Mansel RE (1993) Psychiatric illness in patients with severe treatment-resistant mastalgia. Gen Hosp Psychiatry 15:55–57
Ader DN, South-Paul J, Adera T, Deuster PA (2001) Cyclical mastalgia: prevalence and associated health and behavioral factors. J Psychosom Obstet Gynaecol 22:71–76
Demirel Yılmaz E, Deveci E, Kadıoğlu H et al (2014) Anxiety and depression levels and personality traits of mastalgia patients. J Psychiatry 17:118. https://doi.org/10.4172/Psychiatry.1000118
Topçuoğlu V, Kuşçu MK, Gımzal A et al (2003) Alexithymia, depression and anxiety levels in mastalgia patients: a controlled study. Yeni Symp 41:178–181
Barsky AJ, Goodson JD, Lane RS, Cleary PD (1988) The amplification of somatic symptoms. Psychosom Med 50:510–519
Köteles F, Witthöft M (2017) Somatosensory amplification – an old construct from a new perspective. J Psychosom Res 101:1–9. https://doi.org/10.1016/j.jpsychores.2017.07.011
Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Hisli N (1988) Beck depresyon envanteri’nin geçerliği üzerine bir çalışma. Türk Psikol Derg 22:118–126
Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893–897
Ulusoy M, Sahin NH, Erkmen H (1998) Turkish version of the Beck Anxiety Inventory: psychometric properties. J Cogn Psychother 12:163–172
Barsky AJ, Wyshak G, Klerman GL (1990) The somatosensory amplification scale and its relationship to hypochondriasis. J Psychiatr Res 24:323–334
Güleç H, Sayar K (2007) Reliability and validity of the Turkish form of the Somatosensory Amplification Scale. Psychiatry Clin Neurosci 61:25–30. https://doi.org/10.1111/j.1440-1819.2007.01606.x
Salkovskis PM, Rimes KA, Warwick HMC, Clark DM (2002) The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med 32:843–853
Aydemir Ö, Kirpinar İ, Sati T, Uykur B, Cengisiz C (2013) Reliability and validity of the Turkish version of the Health Anxiety Inventory. Arch Neuropsychiatry 50:325–331. https://doi.org/10.4274/npa.y6383
Kanat BH, Atmaca M, Girgin M, Ilhan YS, Bozdağ A, Özkan Z, Yazar FM, Emir S (2016) Effects of mastalgia in young women on quality of life, depression, and anxiety levels. Indian J Surg 78:96–99. https://doi.org/10.1007/s12262-015-1325-5
Khan SA, Apkarian AV (2002) The characteristics of cyclical and non-cyclical mastalgia: a prospective study using a modified McGill Pain Questionnaire. Breast Cancer Res Treat 75:147–157. https://doi.org/10.1023/A:1019685829799
Holland PA, Gateley CA (1994) Drug therapy of mastalgia. Drugs 48:709–716. https://doi.org/10.2165/00003495-199448050-00005
Colegrave S, Holcombe C, Salmon P (2001) Psychological characteristics of women presenting with breast pain. J Psychosom Res 50:303–307. https://doi.org/10.1016/S0022-3999(01)00196-9
Aksu G, Hocaoğlu Ç (2004) The study of alexithymia, anxiety, worry and depression levels of the patients who suffered by mastalgia and underwent to radiodiagnostic assay. Klin Psikiyatr 7:95–102
Simon GE, VonKorff M (1991) Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area study. Am J Psychiatry 148:1494–1500. https://doi.org/10.1176/ajp.148.11.1494
Kumar V, Avasthi A, Grover S (2018) Somatosensory amplification, health anxiety, and alexithymia in generalized anxiety disorder. Ind Psychiatry J 27:47–52. https://doi.org/10.4103/ipj.ipj_72_17
Yavuz BG, Aydinlar EI, Dikmen PP, Incesu C (2013) Association between somatic amplification, anxiety, depression, stress and migraine. J Headache Pain 14:53. https://doi.org/10.1186/1129-2377-14-53
Kivrak Y, Kose Ozlece H, Ustündag MF, Asoglu M (2016) Pain perception: predictive value of sex, depression, anxiety, somatosensory amplification, obesity, and age. Neuropsychiatr Dis Treat 12:1913–1918. https://doi.org/10.2147/NDT.S106974
Torvik FA, Ystrom E, Czajkowski N, Tambs K, Røysamb E, Ørstavik R, Knudsen GP, Kendler KS, Reichborn-Kjennerud T (2015) Socioeconomic status and sick leave granted for mental and somatic disorders: a prospective study of young adult twins. BMC Public Health 15:134. https://doi.org/10.1186/s12889-015-1457-3
Lipowski ZJ (1990) Somatization and depression. Psychosomatics 31:13–21. https://doi.org/10.1016/S0033-3182(90)72212-8
Eren T, Aslan A, Ozemir IA, Baysal H, Sagiroglu J, Ekinci O, Alimoglu O (2016) Factors effecting mastalgia. Breast Care 11:188–193. https://doi.org/10.1159/000444359
Acknowledgments
The authors would like to thank Cicek Hocaoglu for the scientific editorial assistance.
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the local Ethics Committee of Yozgat Bozok University with a protocol number of 2017-KAEK-189_2018.06.06_04 and performed under the ethical principles of the Declaration of Helsinki for medical research involving human subjects.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hacimusalar, Y., Talih, T. & Karaaslan, O. How Do Health Anxiety, Somatosensory Amplification, and Depression Levels Relate to Non-cyclical Mastalgia? A Case–Control Study. Indian J Surg 82, 578–584 (2020). https://doi.org/10.1007/s12262-019-02014-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-019-02014-y